Loading ...

Don Whitehouse

Immune Tolerance Network

Director, Research Operations

http://www.immunetolerance.org

Assessment Group

dwhitehouse@immunetolerance.org

Work:

415-353-4426

Mobile:

240-281-8075

Address:

Immune Tolerance Network

Committees:

,

Studies:

ITN001AD

-

Allergen ISS Conjugates in Allergic Rhinitis

ITN016AD

-

ITN019AD

-

Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies

ITN025AD

-

Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study

ITN026AI

-

Miller ITN026AI

ITN031AD

-

Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug

ITN032AD

-

Promoting Tolerance to Peanut in High-Risk Children

ITN043AD

-

Long-Term Effects of Sublingual Grass Therapy

ITN048AD

-

ITN049AD

-

Persistence of Oral Tolerance to Peanut

ITN050AD

-

Peanut Oral Immunotherapy in Children

ITN052AD

-

Peanut Protein Quantification Study for LEAP

ITN053AD

-

Peanut protein quantification study for LEAP-ON

ITN057AD

-

Anti-TSLP (AMG 157) Plus Antigen-Specific Immunotherapy for Induction of Tolerance in Individuals With Cat Allergy

ITN060AD

-

Peanut Allergy Sensitisation Study

ITN061AD

-

Cat Pilot Study - Environmental Exposure Chamber (EEC) vs. Nasal Allergen Challenge (NAC)

ITN068AD

-

GLA plus antigen-specific immunotherapy for induction of tolerance in individuals with cat allergy

ITN070AD

-

ITN071AD

-

ITN072AD

-

GLA-AF plus antigen-specific immunotherapy in individuals with seasonal allergic rhinitis

ITN076AD

-

Food Exposure Allergy Suppression Trial Pilot Study

ITN082AD

-

Atopic Dermatitis Dupilumab and anti-OX40 Treatment for Sustained Efficacy

ITN084AD

-

Grass Pollen Immunotherapy plus Dupilumab for Tolerance Induction

ITN088AD

-

ITN502AS

-

ITN509AI

-

QC Protocol ITN509AI

ITN520AD

-

ITN526AD

-

ITN817AD

-

ITN820AD

-

ITN824AD

-

Bio:

Admin Links

Shortcuts

ITN Documents

Links